Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus

Evaluation of the Potential Impact of Ebola Virus Genomic Drift on the Efficacy of Sequence-Based Candidate Therapeutics

(2015) Jeffrey R. Kugelman et al.   mBio

Neurovirulence and Immunogenicity of Attenuated Recombinant Vesicular Stomatitis Viruses in Nonhuman Primates

(2014) D. K. Clarke et al.   JOURNAL OF VIROLOGY

Emergence of Zaire Ebola Virus Disease in Guinea

(2014) Sylvain Baize et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak

(2014) S. K. Gire et al.   SCIENCE

Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA

(2014) E. P. Thi et al.   Science Translational Medicine

Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop

(2014) Rona Hirschberg et al.   Viruses-Basel

Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection

(2012) Jeffrey R. Kugelman et al.   PLoS One

Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates

(2012) Chad E. Mire et al.   PLoS Neglected Tropical Diseases

Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus

(2012) Gopi S. Mohan et al.   PLoS Pathogens

Genomic RNA Editing and Its Impact on Ebola Virus Adaptation During Serial Passages in Cell Culture and Infection of Guinea Pigs

(2011) Valentina A. Volchkova et al.   JOURNAL OF INFECTIOUS DISEASES

In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation

(2009) J. Erik Johnson et al.   VACCINE